Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Hanazono

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Blood|August 8, 1998
Ex vivo expansion of genetically marked rhesus peripheral blood progenitor cells results in diminished long-term repopulating abilityJ F Tisdale, Y Hanazono, S E Sellers, et al.
International Journal of Hematology|June 1, 1992
Treatment of acute nonlymphocytic leukemia by combination of recombinant human granulocyte colony-stimulating factor and cytotoxic agents: a report of six casesY Hanazono, K Miyazono, Y F Piao, et al.
Biochemical and Biophysical Research Communications|June 15, 1995
Tyrosine phosphorylation of vav protooncogene product in primary human myelogenous leukemic cells stimulated by granulocyte colony-stimulating factorA Yuo, S Kitagawa, S Iki, et al.
Blood|September 25, 1999
In vivo marking of rhesus monkey lymphocytes by adeno-associated viral vectors: direct comparison with retroviral vectorsY Hanazono, K E Brown, A Handa, et al.
Biochemical and Biophysical Research Communications|November 2, 1995
TPO/c-mpl ligand induces tyrosine phosphorylation of multiple cellular proteins including proto-oncogene products, Vav and c-Cbl, and Ras signaling moleculesK Sasaki, H Odai, Y Hanazono, et al.
Gene Therapy|July 26, 2002
In vivo selective expansion of gene-modified hematopoietic cells in a nonhuman primate modelY Hanazono, T Nagashima, M Takatoku, et al.
Gene Therapy|April 18, 2002
Delayed delivery of AAV-GDNF prevents nigral neurodegeneration and promotes functional recovery in a rat model of Parkinson's diseaseL Wang, S Muramatsu, Y Lu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 10, 2000
Introduction of a xenogeneic gene via hematopoietic stem cells leads to specific tolerance in a rhesus monkey modelD A Heim, Y Hanazono, N Giri, et al.
Gene Therapy|October 22, 2004
Adeno-associated virus vector-mediated interleukin-10 gene transfer inhibits atherosclerosis in apolipoprotein E-deficient miceT Yoshioka, T Okada, Y Maeda, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Blood|August 8, 1998
Ex vivo expansion of genetically marked rhesus peripheral blood progenitor cells results in diminished long-term repopulating abilityJ F Tisdale, Y Hanazono, S E Sellers, et al.
International Journal of Hematology|June 1, 1992
Treatment of acute nonlymphocytic leukemia by combination of recombinant human granulocyte colony-stimulating factor and cytotoxic agents: a report of six casesY Hanazono, K Miyazono, Y F Piao, et al.
Biochemical and Biophysical Research Communications|June 15, 1995
Tyrosine phosphorylation of vav protooncogene product in primary human myelogenous leukemic cells stimulated by granulocyte colony-stimulating factorA Yuo, S Kitagawa, S Iki, et al.
Blood|September 25, 1999
In vivo marking of rhesus monkey lymphocytes by adeno-associated viral vectors: direct comparison with retroviral vectorsY Hanazono, K E Brown, A Handa, et al.
Biochemical and Biophysical Research Communications|November 2, 1995
TPO/c-mpl ligand induces tyrosine phosphorylation of multiple cellular proteins including proto-oncogene products, Vav and c-Cbl, and Ras signaling moleculesK Sasaki, H Odai, Y Hanazono, et al.
Gene Therapy|July 26, 2002
In vivo selective expansion of gene-modified hematopoietic cells in a nonhuman primate modelY Hanazono, T Nagashima, M Takatoku, et al.
Gene Therapy|April 18, 2002
Delayed delivery of AAV-GDNF prevents nigral neurodegeneration and promotes functional recovery in a rat model of Parkinson's diseaseL Wang, S Muramatsu, Y Lu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 10, 2000
Introduction of a xenogeneic gene via hematopoietic stem cells leads to specific tolerance in a rhesus monkey modelD A Heim, Y Hanazono, N Giri, et al.
Gene Therapy|October 22, 2004
Adeno-associated virus vector-mediated interleukin-10 gene transfer inhibits atherosclerosis in apolipoprotein E-deficient miceT Yoshioka, T Okada, Y Maeda, et al.
Pageof 4